Multimodality CT imaging contributes to improving the diagnostic accuracy of solitary pulmonary nodules: a multi-institutional and prospective study
, , , , , , , , , , , , , , , and
Feb 17, 2023
About this article
Article Category: Research Article
Published Online: Feb 17, 2023
Page range: 20 - 34
Received: Aug 15, 2022
Accepted: Dec 05, 2022
DOI: https://doi.org/10.2478/raon-2023-0008
Keywords
© 2023 Gaowu Yan, Hongwei Li, Xiaoping Fan, Jiantao Deng, Jing Yan, Fei Qiao, Gaowen Yan, Tao Liu, Jiankang Chen, Lei Wang, Yang Yang, Yong Li, Linwei Zhao, Anup Bhetuwal, Morgan A. McClure, Na Li, Chen Peng, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7
![Receiver operating characteristic curves for distinguishing benign from malignant nodules using dual-energy CT parameters.
aOL = Iodine overlay at the arterial phase (AUC = 0.636); vOL = Iodine overlay at the venous phase (AUC = 0.638); aIC = Iodine concentration at the arterial phase (AUC = 0.657); vIC = Iodine concentration at the venous phase (area under the curve [AUC] = 0.703); aNIC = normalized iodine concentration at the arterial phase (AUC = 0.728); vNIC = normalized iodine concentration at the venous phase (AUC = 0.790); all p values < 0.05](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647356744e662f30ba53ab78/j_raon-2023-0008_fig_007.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=AKIA6AP2G7AKOUXAVR44%2F20250912%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20250912T235426Z&X-Amz-Expires=3600&X-Amz-Signature=bda02413afd6cfe55b640002afef70a781c38ae592c146c198dcb724b08e6863&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Solitary pulmonary nodules evaluated with CT perfusion imaging
Parameters* | Benign SPNs (n = 118) | Malignant SPNs (n = 167) | |
---|---|---|---|
BF (ml/100 g/min) | 49.34 (27.78, 72.81) | 58.44 (24.91, 80.47) | 0.1022 |
BV (ml/100 g) | 4.79 (2.87, 7.66) | 4.84 (2.90, 7.74) | 0.1829 |
MTT (s) | 6.71 (3.05, 9.58) | 7.66 (3.83, 10.54) | 0.2034 |
PS (ml/100 g/min) | 8.89 (4.94, 12.45) | 14.37 (11.50, 16.29) | < 0.0001 |
Solitary pulmonary nodules evaluated with dual-energy CT
Parameters | AUC | Threshold | Sensitivity | Specificity | 95% CI | |
---|---|---|---|---|---|---|
aOL (HU) | 0.636 | 13.89 | 70.66 | 61.02 | 0.577–0.692 | < 0.001 |
vOL (HU) | 0.638 | 12.79 | 59.88 | 72.03 | 0.580–0.694 | < 0.001 |
aIC (mg/ml) | 0.657 | 0.65 | 67.66 | 69.49 | 0.599–0.712 | < 0.001 |
vIC (mg/ml) | 0.703 | 0.85 | 68.86 | 71.19 | 0.646–0.755 | < 0.001 |
aNIC | 0.728 | 0.12 | 67.66 | 74.58 | 0.672–0.778 | < 0.001 |
vNIC | 0.790 | 0.35 | 75.45 | 80.51 | 0.738–0.836 | 0.0001 |
Step-wise approach of multimodality CT imaging for evaluating solitary pulmonary nodules14647
1. Solid | ||
Density | 2. Subsolid | |
3. Round or oval | ||
Shape | 4. Triangular or polygonal | |
5. Smooth | ||
Margins | 6. Lobulated | |
7. Spiculated | ||
Non-contrast enhanced CT | 8. Fat | |
Internal characteristics | 9. Calcification | |
10. Cavitation | ||
11. Pleural retraction | ||
12. Air bronchogram | ||
Some complex findings | 13. Bubble like lucencies (pseudocavitation) | |
14. Cystic airspace | ||
15. Vascular convergence | ||
Contrast enhanced CT | Parameter (s) | 16. Degree of enhancement |
CT perfusion imaging | Parameter (s) | 17. Permeability surface |
Dual-energy CT | Parameter (s) | 18. Normalized iodine concentration at the venous phase |
Solitary pulmonary nodules (SPNs) evaluated with dual-energy CT
Parameters* | Benign SPNs (n = 118) | Malignant SPNs (n = 167) | |
---|---|---|---|
aOL (HU) | 13.24 (10.97, 21.58) | 19.58 (13.29, 26.07) | < 0.0001 |
vOL (HU) | 11.09 (10.09, 14.86) | 14.99 (10.59, 23.98) | < 0.0001 |
aIC (mg/ml) | 0.69 (0.47, 0.985) | 1.13 (0.70, 1.56) | < 0.0001 |
vIC (mg/ml) | 0.55 (0.44, 1.00) | 0.97 (0.50, 1.46) | < 0.0001 |
aNIC | 0.10 (0.06, 0.13) | 0.18 (0.11, 0.25) | < 0.0001 |
vNIC | 0.23 (0.13, 0.32) | 0.54 (0.43, 0.65) | < 0.0001 |
Pathological results of the 285 solitary pulmonary nodules (SPNs) included in this study
SPNs | Pathology | Datum (%) |
---|---|---|
Tuberculosis | 46 (29.0%) | |
Acute and chronic inflammation | 32 (27.1%) | |
Inflammatory pseudotumor | 14 (11.9%) | |
Hamartoma | 9 (7.6%) | |
Pulmonary sclerosing hemangioma | 6 (5.1%) | |
Sequestration | 4 (3.4%) | |
Bronchogenic cyst | 3 (2.5%) | |
Rheumatoid arthritis | 2 (1.7%) | |
Granulomatosis with polyangiitis | 2 (1.7%) | |
Primary pulmonary carcinoma | 116 (69.5%) | |
Solitary metastasis | 23 (13.8%) | |
Primary lung neuroendocrine tumor | 21 (12.6%) | |
Primary pulmonary lymphoma | 7 (4.2%) |
Solitary pulmonary nodules evaluated with multimodality CT imaging
Methods* | Sensitivity (%) | Specificity (%) | Accuracy (%) | PPV (%) | NPV (%) |
---|---|---|---|---|---|
Method A | 83.23 | 63.56 | 75.09 | 76.37 | 72.82 % |
Method B | 85.63 | 67.80 | 78.25 | 79.01 | 76.92 % |
Method C | 84.43 | 66.10 | 76.84 | 77.90 | 75.00 % |
Method A+B | 94.61 | 74.58 | 86.32 | 84.04 | 90.72 % |
Method A+C | 92.81 | 77.97 | 86.67 | 85.64 | 88.46 % |
Method B+C | 95.81 | 81.36 | 89.82 | 87.91 | 93.20 % |
Method A+B+C | 97.60 | 88.14 | 93.68 | 92.09 | 96.30 % |
Pairwise comparison of AUC of dual energy CT parameters in 285 patients with solitary pulmonary nodules
Parameters* | ||
---|---|---|
aOL |
0.0995 | 0.9207 |
aOL |
0.813 | 0.4162 |
aOL |
2.485 | 0.0129 |
aOL |
3.171 | 0.0015 |
aOL |
5.170 | < 0.0001 |
vOL |
0.702 | 0.4829 |
vOL |
2.567 | 0.0103 |
vOL |
3.280 | 0.0010 |
vOL |
5.345 | < 0.0001 |
aIC |
2.034 | 0.0420 |
aIC |
2.755 | 0.0059 |
aIC |
4.728 | < 0.0001 |
vIC |
1.036 | 0.3001 |
vIC |
3.227 | 0.0013 |
aNIC |
2.708 | 0.0068 |
Patient characteristics in 285 patients with solitary pulmonary nodules
Characteristics | Pathology |
||
---|---|---|---|
Benign SPNs (n = 118) | Malignant SPNs (n = 167) | ||
Male | 56 (47.46%) | 96 (57.49%) | |
Female | 62 (52.54%) | 71 (42.51%) | 0.1170 |
50.84 ± 19.60 | 52.93 ± 20.30 | 0.3952 | |
Yes | 52 (44.07%) | 81 (48.50%) | |
No | 66 (55.93%) | 86 (51.50%) | 0.4721 |
Yes | 17 (14.41%) | 28 (16.77%) | |
No | 101 (85.59%) | 139 (83.23%) | 0.6245 |
Normal | 103 (87.29%) | 139 (83.23%) | 0.4026 |
Abnormal | 15 (12.71%) | 28 (16.77%) |
Non-enhanced computed tomography (NECT) in evaluating solitary pulmonary nodules (SPNs) with various categories in 285 patients
Items | Category I | Category II | Category III | Category IV | Category V |
---|---|---|---|---|---|
Benign SPNs (n = 118) | 39 | 9 | 48 | 22 | 0 |
Malignant SPNs (n = 167) | 0 | 5 | 54 | 19 | 89 |
Solitary pulmonary nodules evaluated with non-contrast enhanced CT
CT findings* | Benign SPNs (n = 118) | Malignant SPNs (n = 167) | |
---|---|---|---|
Yes | 84 (71.19%) | 49 (29.34%) | < 0.0001 |
No | 34 (28.81%) | 118 (70.66%) | |
Yes | 29 (24.58%) | 115 (68.86%) | |
No | 89 (75.42%) | 52 (31.14%) | < 0.0001 |
Yes | 25 (21.19%) | 108 (78.81%) | |
No | 93 (64.67%) | 59 (35.33%) | < 0.0001 |
Yes | 13 (11.02%) | 38 (22.75%) | 0.0120 |
No | 105 (88.98%) | 129 (77.25%) | |
Yes | 9 (7.63%) | 16 (9.58%) | |
No | 109 (92.37%) | 151 (90.42%) | 0.6727 |
Yes | 33 (27.97%) | 56 (33.53%) | 0.3643 |
No | 85 (72.03%) | 111 (66.47%) | |
Yes | 10 (8.47%) | 6 (3.59%) | |
No | 108 (91.53%) | 161 (96.41%) | 0.1149 |
Yes | 6 (5.08%) | 4 (2.40%) | 0.3277 |
No | 112 (94.92%) | 163 (97.60%) | |
Yes | 25 (21.19%) | 89 (53.29%) | < 0.0001 |
No | 93 (78.81%) | 78 (46.71%) | |
Yes | 33 (27.97%) | 84 (50.30%) | 0.0002 |
No | 85 (72.03%) | 83 (49.70%) | |
Yes | 26 (22.03%) | 43 (25.75%) | 0.4867 |
No | 92 (77.97%) | 124 (74.25%) | |
Upper and middle lobes | 53 (44.92%) | 79 (47.31%) | 0.7186 |
Inferior lobe | 65 (55.08%) | 88 (52.69%) | |
15–20 | 29 (24.58%) | 46 (27.54%) | 0.5883 |
20–30 | 89 (75.42%) | 121 (72.46%) |